Top 3 Health Care Stocks That May Keep You Up At Night In Q3
As of Aug. 27, 2026, three health care stocks are overbought and could be giving a real warning to momentum investors, according to the RSI indicator.
Read original at benzingaStocks · News reference
Canaccord Genuity Maintains Buy on Pulse Biosciences, Raises Price Target to $43
Canaccord Genuity analyst William Plovanic maintains Pulse Biosciences (NASDAQ:PLSE) with a Buy and raises the price target from $32 to $43.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 10, 2026, 12:05 PM
- Checked
- Aug 10, 2026, 12:05 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
This Okta Analyst Turns Bullish; Here Are Top 3 Upgrades For Monday
Top Wall Street analysts changed their outlook on top stocks. See analyst ratings and price targets for PMT, ALAB.
Read original at benzingaThis Workday Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
WALL analysts changed outlook on top names. See upgrades, downgrades & initiations on analyst ratings page. Workday downgraded, price target cut.
Read original at benzingaThis Onto Innovation Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Top Wall Street analysts changed outlook on top names. See analyst rating changes on Benzinga's page. Analysts have positive views on ONTO stock.
Read original at benzinga